| Placebo (n = 6) | Ascorbic acid (n = 5) |  |  |
---|---|---|---|---|
 | Change | Change | Difference | Pvalue |
Median nerve MNCV (m/s)a | -0.8 (0.9) | 0.5 (1.5) | 1.3 (-0.3-3.0) | 0.11 |
Median nerve minimal F response latency (ms)a | 3.5 (8.0)* | -5.6 (4.4) | -9.1 (-18.5-0.3) | 0.06 |
CMAP amplitude abductor pollicis brevis muscle (mV)a | -0.02 (0.9) | -0.2 (0.8) | -0.1 (-1.3 -1.1) | 0.79 |
Three point grip (N)a | -3.0 (9.2) | 3.4 (9.0) | 6.4 (-6.1-18.9) | 0.28 |
Foot dorsiflexors (N)a | -5.1 (17.6) | 0.6 (15.6) | 5.6 (-17.3-28.6) | 0.59 |
ISSb | 0 (-4-1) | -2 (-2-1) | -2 (-2-2) | 0.30 |
CMTNSb | 1 (-5-4) | -2 (-3-1) | -3 (-6-3) | 0.14 |
ODSSb | 0 (0-1) | 0 (-2-0) | 0 (-2-0) | 0.18 |
ALDSa | 1.0 (3.7) | 0.3 (0.4) | -0.6 (-4.5-3.2) | 0.30 |
Nine hole peg test (s)a | -3.5 (2.8) | -2.0 (1.8) | 1.5 (-1.8-4.8) | 0.32 |
50 m walking (s)a | -0.6 (1.9) | -0.9 (1.8) | -0.3 (-2.9-2.2) | 0.77 |